BDBM72423 Step A: (10S)-2,8,9-Trifluoro-10-methyl-3-(trifluoromethyl)-10,11,12,13-tetrahydro-19H-5,18-methanodibenzo[f,i]pyrido[2,3-b][1,4,8]triazacyclotridecin-15,19(14H)-dione (10R)-2,8,9-Trifluoro-10-methyl-3-(trifluoromethyl)-10,11,12,13-tetrahydro-19H-5,18-methanodibenzo[f,i]pyrido[2,3-b][1,4,8]triazacyclotridecine-15,19(14H)-dione::US20250368647, Example 132

SMILES CC1CCNc2[nH]c(=O)ccc2N2CN(c3cc(C(F)(F)F)c(F)cc3C2=O)c2ccc(F)c(F)c21

InChI Key InChIKey=SIRPFDVSEVZJMO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72423   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72423BDBM72423(Step A: (10S)-2,8,9-Trifluoro-10-methyl-3-(trifluo...)
Affinity DataIC50: 6.31nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
PCBioAssay